APA (7th ed.) Citation

H, K., EB, L., S, L., TH, G., JY, L., SH, L., . . . SP, H. (2023). Dipeptidyl peptidase-4 inhibitors increase the risk of bullous pemphigoid in older patients with diabetes: A retrospective analysis using the Korean National Health Insurance Database. Journal of the European Academy of Dermatology and Venereology : JEADV, 37(7), e879. https://doi.org/10.1111/jdv.18975

Chicago Style (17th ed.) Citation

H, Kang, Lee EB, Lee S, Go TH, Lee JY, Lee SH, Song SA, Lim HK, and Hong SP. "Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Bullous Pemphigoid in Older Patients with Diabetes: A Retrospective Analysis Using the Korean National Health Insurance Database." Journal of the European Academy of Dermatology and Venereology : JEADV 37, no. 7 (2023): e879. https://doi.org/10.1111/jdv.18975.

MLA (9th ed.) Citation

H, Kang, et al. "Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Bullous Pemphigoid in Older Patients with Diabetes: A Retrospective Analysis Using the Korean National Health Insurance Database." Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 37, no. 7, 2023, p. e879, https://doi.org/10.1111/jdv.18975.